These results seem to indicate that tumor suppression is partially mediated by an increase in GSK-3β and a decrease in cyclin D1 levels, which suggests that cyclin D1 levels can be reduced by the activation of GSK-3β that phosphorylates cyclin D1, leading to its proteolysis [73]. The gene discussed is GSK3B; the disease is neoplasm.